Clinical Trial

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-06-14; most recent amendment 2025-05-07.
Status change: Not Yet Recruiting → Recruiting 2024-09-11
Trial Details
NCT Number NCT05917587
Lead Sponsor Anna Stanhewicz, PhD
Conditions Gestational Diabetes
Enrollment 30 participants
Start Date 2024-09-11
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-13